Table 1 TCGA-HNSC patient characteristics.
Characteristic | Levels | Low expression of ALDH2 | High expression of ALDH2 |
|---|---|---|---|
n | 251 | 251 | |
Gender, n (%) | Female | 63 (12.5%) | 71 (14.1%) |
Male | 188 (37.5%) | 180 (35.9%) | |
Age, n (%) | < = 60 | 124 (24.8%) | 121 (24.2%) |
> 60 | 127 (25.3%) | 129 (25.7%) | |
T stage, n (%) | T1 | 13 (2.7%) | 20 (4.1%) |
T2 | 63 (12.9%) | 81 (16.6%) | |
T3 | 75 (15.4%) | 56 (11.5%) | |
T4 | 90 (18.5%) | 89 (18.3%) | |
N stage, n (%) | N0 | 106 (22.1%) | 133 (27.7%) |
N1 | 38 (7.9%) | 42 (8.8%) | |
N2 | 85 (17.7%) | 69 (14.4%) | |
N3 | 6 (1.2%) | 1 (0.2%) | |
M stage, n (%) | M0 | 234 (49.1%) | 238 (49.9%) |
M1 | 2 (0.4%) | 3 (0.6%) | |
Clinical stage, n (%) | Stage I | 7 (1.4%) | 12 (2.5%) |
Stage II | 42 (8.6%) | 53 (10.9%) | |
Stage III | 54 (11.1%) | 48 (9.8%) | |
Stage IV | 138 (28.3%) | 134 (27.5%) | |
Alcohol history, n (%) | No | 70 (14.3%) | 88 (17.9%) |
Yes | 176 (35.8%) | 157 (32%) | |
Race, n (%) | Asian | 7 (1.4%) | 3 (0.6%) |
Black or African American | 29 (6%) | 18 (3.7%) | |
White | 207 (42.7%) | 221 (45.6%) | |
Age, median (IQR) | 61 (52, 69) | 61 (55, 69) |
